Marshall Wace’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Buy
+12,343
New +$1.4M ﹤0.01% 2004
2025
Q4
Sell
-50,609
Closed -$4.74M 2904
2025
Q3
$4.74M Buy
50,609
+28,503
+129% +$2.65M ﹤0.01% 1203
2025
Q2
$1.92M Buy
+22,106
New +$1.85M ﹤0.01% 1583
2025
Q1
Sell
-7,779
Closed -$753K 2578
2024
Q4
$753K Sell
7,779
-103
-1% -$10.4K ﹤0.01% 1868
2024
Q3
$747K Buy
+7,882
New +$688K ﹤0.01% 1769
2020
Q2
Sell
-6,473
Closed -$257K 1487
2020
Q1
$257K Sell
6,473
-29,310
-82% -$1.24M ﹤0.01% 1128
2019
Q4
$1.59M Sell
35,783
-147,419
-80% -$5.67M 0.01% 869
2019
Q3
$6.27M Sell
183,202
-134,618
-42% -$4.66M 0.05% 434
2019
Q2
$12M Sell
317,820
-361,431
-53% -$12.4M 0.1% 238
2019
Q1
$20.8M Buy
+679,251
New +$20.7M 0.2% 116

Other funds holding ACA

Marshall Wace's ACA Position: Q1 2026 in Review

Marshall Wace opened a new position in Arcosa (ACA) in Q1 2026: 12,343 shares worth $1.31M. The stake represents ﹤0.01% of the portfolio and ranks #2004 among its holdings. This is a return to the name: Marshall Wace previously reported a position in ACA as recently as Q3 2025.

Marshall Wace first reported a position in ACA in Q1 2019 and has held it in 10 quarters since. The position peaked at $20.8M in Q1 2019. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

  • Marshall Wace held 12,343 shares of Arcosa worth $1.31M as of Q1 2026.
  • Arcosa was a new Marshall Wace position in Q1 2026.
  • Arcosa made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2004 holding.
  • Marshall Wace first reported a position in Arcosa in Q1 2019 and has held it in 10 quarters since.
  • Marshall Wace's Arcosa position peaked at $20.8M in Q1 2019.
  • 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.